Québec leads the way by being the first province to list MetroGel(R) 1% (metronidazole topical gel, 1%) on its provincial formulary for the treatment of rosacea - a facial skin disease thataffects an estimated two million Canadians(1). MetroGel is the most commonly prescribed topical medication for rosacea(2). The new 1% formulation provides a convenient once-daily dosing for individuals who suffer from this skin condition.
The details can be read here.
No comments:
Post a Comment